11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial
- 2011
- Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
- Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
- 2010
-
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-na
- Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients
- 2009
- Treatment of HIV infection: Swedish recommendations 2009
- 2008
- Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007
- Treatment of chronic hepatitis B infection: An update of Swedish recommendations
- 1999
-
Long-term pattern of HIV-1 RNA load in perinatally infected children
Navér, Lars ; Ehrnst, Anneka ; Belfrage, Erik ; Sönnerborg, Anders ; Lidin-Janson, Gunilla ; Christensson, Bertil LU ; Ljung, Rolf LU
and Bohlin, Ann-Britt
(1999)
In Scandinavian Journal of Infectious Diseases
31(4).
p.337-343
Mark